Authors:
GREENBLATT DJ
HARMATZ JS
VONMOLTKE LL
EHRENBERG BL
HARREL L
CORBETT K
COUNIHAN M
GRAF JA
DARWISH M
MERTZANIS P
MARTIN PT
CEVALLOS WH
SHADER RI
Citation: Dj. Greenblatt et al., COMPARATIVE KINETICS AND DYNAMICS OF ZALEPLON, ZOLPIDEM, AND PLACEBO, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 553-561
Authors:
DROVER DR
LEMMENS HJM
NAIDU S
CEVALLOS WH
TROY S
MARTIN PT
STANSKI DR
Citation: Dr. Drover et al., DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSSOVER, PHARMACODYNAMIC STUDY OF 10 AND 20 MG DOSES OF ZALEPLON AND ZOLPIDEM, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 105-105
Authors:
BONI JP
DECLEENE SA
CEVALLOS WH
HICKS DR
KORTHBRADLEY JM
Citation: Jp. Boni et al., EFFECTS OF AGE AND GENDER ON THE PHARMACOKINETICS OF BROMFENAC IN HEALTHY-VOLUNTEERS, The Annals of pharmacotherapy, 31(4), 1997, pp. 400-405
Authors:
BONI JP
CEVALLOS WH
DECLEENE S
KORTHBRADLEY JM
Citation: Jp. Boni et al., THE INFLUENCE OF BROMFENAC ON THE PHARMACOKINETICS AND PHARMACODYNAMIC RESPONSES TO GLYBURIDE IN DIABETIC SUBJECTS, Pharmacotherapy, 17(4), 1997, pp. 783-790
Authors:
GUMBHIRSHAH K
CEVALLOS WH
DECLEENE SA
KORTHBRADLEY JM
Citation: K. Gumbhirshah et al., EVALUATION OF PHARMACOKINETIC INTERACTION BETWEEN BROMFENAC AND PHENYTOIN IN HEALTHY-MALES, Journal of clinical pharmacology, 37(2), 1997, pp. 160-168
Authors:
ERMER JC
BONI JP
CEVALLOS WH
DECLEENE S
BURGHART P
RUDNICK MR
FRUNCILLO RJ
BERNS JS
COHEN RM
Citation: Jc. Ermer et al., BROMFENAC DISPOSITION IN PATIENTS WITH IMPAIRED KIDNEY-FUNCTION, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 312-318
Authors:
KORTHBRADLEY JM
CEVALLOS WH
MCPHERSON MK
DECLEENE SA
NEEFE DL
Citation: Jm. Korthbradley et al., PK PD EVALUATION OF THE POTENTIAL INTERACTION BETWEEN BROMFENAC AND WARFARIN/, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 124-124